0001437749-24-004361.txt : 20240215 0001437749-24-004361.hdr.sgml : 20240215 20240215161727 ACCESSION NUMBER: 0001437749-24-004361 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krempa David CENTRAL INDEX KEY: 0001968254 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38738 FILM NUMBER: 24644034 MAIL ADDRESS: STREET 1: 29125 W FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001710340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 371858472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7278 BUSINESS PHONE: (847) 787-7361 MAIL ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7278 4 1 rdgdoc.xml FORM 4 X0508 4 2024-02-13 0001710340 Eton Pharmaceuticals, Inc. ETON 0001968254 Krempa David C/O ETON PHARMACEUTICALS, INC. 21925 W. FIELD PARKWAY, SUITE 235 DEERPARK IL 60010-7208 1 Chief Business Officer 0 Stock Option (Right to buy) 4.42 2024-02-13 4 A 0 144677 0 A 2034-02-12 Common Stock 144677 813430 D The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028. The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration. /s/ David Krempa 2024-02-15